White label ELPA - ClinicalTrials.eu

Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

Recruiting

4 1
Investigated Drugs:
- Recombinant Human Surfactant Protein-D
+2
Study of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
Study of Lower Dose Olaparib Combined with Cobicistat to Improve Treatment Tolerance in Cancer Patients

Recruiting

3 1 1 1
Investigated Drugs:
Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

Recruiting

2 1 1
Investigated Diseases:
- Neurofibromatosis
Investigated Drugs:
- Bevacizumab Zirconium Zr-89
Study on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
Evaluating SGM-101 (fluorochrome-labeled antibody) in patients with locally advanced or recurrent rectal cancer undergoing surgery

Recruiting

2 1 1
Investigated Diseases:
- Rectal cancer
Investigated Drugs:
- Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Study on the Effect of Recombinant Human Interferon Gamma 1b for Patients with Post-Aggressive Immunosuppression in Intensive Care

Recruiting

3 1 1
Investigated Diseases:
- Immunosuppression
Investigated Drugs:
- Recombinant Human Interferon Gamma 1B
- Sodium Chloride
Study on Reducing Inflammation After Cataract Surgery Using Nepafenac and Dexamethasone for Patients Undergoing Surgery

Recruiting

3 1 1 1
Investigated Drugs:
- Nepafenac
- Dexamethasone
Study on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Evaluation of drug combination therapy (olaparib, nilotinib, tremelimumab, and durvalumab) for patients with advanced or metastatic solid tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Metastatic neoplasm
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies